Michael S. Wade
Impact in
- Virology top 2%
- HIV Research and Treatment
-
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Pulmonary Hypertension Research and Treatments 8
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
-
- Sarcoidosis and Beryllium Toxicity Research 2
- Co-authors
- Jane Clifford Azizkhan (5 shared papers)Carl P. Arneson (4 shared papers)Andrew James Pierce (1 shared paper)Joe G. N. Garcia (16 shared papers)Thomas L. Hunt (4 shared papers)Roger Jeffs (3 shared papers)Shwu‐Fan Ma (12 shared papers)Dennis Daniel Taub (3 shared papers)
- Journals
- PLoS ONE (4 papers)The Journal of Clinical Pharmacology (3 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Cardiovascular Pharmacology (2 papers)CHEST Journal (2 papers)
- Partner nations
- United StatesSpainRussia
In The Last Decade
Michael S. Wade
52 papers receiving 3.9k citations
Michael S. Wade's Hit Papers
Peers
Comparison fields: 5 of 124
- Virology 259
- Pulmonary and Respiratory Medicine 1.3k
- Ophthalmology 232
- Immunology 416
- Cardiology and Cardiovascular Medicine 423
Countries citing papers authored by Michael S. Wade
This map shows the geographic impact of Michael S. Wade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Wade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Wade more than expected).
Fields of papers citing papers by Michael S. Wade
This network shows the impact of papers produced by Michael S. Wade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Wade. The network helps show where Michael S. Wade may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael S. Wade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study Hit paper breakdown → | 2013 | 476 |
| 2 | 1998 | 366 | |
| 3 | 2006 | 312 | |
| 4 | 2007 | 310 | |
| 5 | Transcription from TATA-less promoters: dihydrofolate reductase as a model. | 1993 | 231 |
| 6 | 1980 | 186 | |
| 7 | 2009 | 171 | |
| 8 | 2004 | 163 | |
| 9 | 2006 | 148 | |
| 10 | 1992 | 108 | |
| 11 | 2008 | 97 | |
| 12 | 2006 | 92 | |
| 13 | 2007 | 85 | |
| 14 | 1995 | 80 | |
| 15 | 2012 | 80 | |
| 16 | 2012 | 77 | |
| 17 | 2003 | 70 | |
| 18 | 2009 | 64 | |
| 19 | 1992 | 62 | |
| 20 | 2012 | 59 |
About Michael S. Wade
Michael S. Wade is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Immunology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 54 papers that have together received 4.0k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (8 papers), Virus-based gene therapy research (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Heart Failure Treatment and Management (3 papers), Peripheral Artery Disease Management (3 papers), Sphingolipid Metabolism and Signaling (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Sarcoidosis and Beryllium Toxicity Research (2 papers). The work is most often cited by research in Virology (259 citations), Pulmonary and Respiratory Medicine (1.3k citations), Ophthalmology (232 citations), Immunology (416 citations) and Cardiology and Cardiovascular Medicine (423 citations). Michael S. Wade has collaborated with scholars based in United States, Spain and Russia. Frequent co-authors include Jane Clifford Azizkhan, Carl P. Arneson, Andrew James Pierce, Joe G. N. Garcia, Thomas L. Hunt, Roger Jeffs, Shwu‐Fan Ma, Dennis Daniel Taub, Ashani T. Weeraratna and Maria M. Mudryj. Their work appears in journals such as PLoS ONE, The Journal of Clinical Pharmacology, Proceedings of the National Academy of Sciences, Journal of Cardiovascular Pharmacology and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.